Michael Schweizer, MD, discusses a prostate cancer study that was presented at the 2021 ASCO Annual Meeting.
Ezra Cohen, MD, FRCPSC, FASCO, San Diego Moores Cancer Center, discusses personalized neoantigen vaccine plus pembrolizumab in adults with advanced cancer, presented at the 2021 ASCO Annual Meeting.
Richard M. Stone, MD, recently shared updates on the treatment of high-risk AML at Miami Cancer Institute’s Second Summit of the Americas on Immunotherapies for Hematologic Malignancies.
Javier Cortes, MD, PhD, International Breast Cancer Center, discusses the role of immunotherapy in the first line treatment of metastatic triple-negative breast cancer, presented at the 2021 Great…
Estefania Labanca, PhD, discusses data on CRPC progression and the use of non-canonical AR signaling and ketone body fuel which were presented at the AACR Annual Meeting.
Yuan Zhang, PhD, and Yi Xiao, PhD, discuss boosting immune surveillance with low-dose PI3K inhibitors to facilitate early intervention of breast cancer.
Leigh Ellis, PhD, discusses efforts of Cedars-Sinai researchers to discover new ways to alter tissues surrounding prostate tumors to help the body fight cancer.
Dr Schroeder spoke on the findings and significance of a study on whole genome sequencing as an alternative to cytogenetic analysis in myeloid cancers.
Stay in the know.
OncNet Newsletter